Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14

Infection and Immunity

Volumn 64, Issue 9, 1996, Pages 3601-3608

  Cunningham, Mark D ^a   Seachord, Carrie ^a   Ratcliffe, Kent ^a   Bainbridge, Brian ^a   Aruffo, Alejandro ^a   Darveau, Richard P ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN;

ANTIGEN BINDING; ANTIGEN RECOGNITION; ARTICLE; ESCHERICHIA COLI; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HOST RESISTANCE; HUMAN; HUMAN CELL; INFECTION RESISTANCE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PORPHYROMONAS; PRIORITY JOURNAL;

EID: 0029758163     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.64.9.3601-3608.1996     Document Type: Article

References (54)

1. Casey, L. C., R. A. Balk, and R. C. Bone. 1993. Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome. Ann. Intern. Med. 119:771-778.
2. Darveau, R. P., M. D. Cunningham, T. Bailey, C. Seachord, K. Ratcliffe, B. Bainbridge, M. Dietsch, R. C. Page, and A. Aruffo. 1995. Ability of bacteria associated with chronic inflammatory disease to stimulate E-selectin expression and promote neutrophil adhesion. Infect. Immun. 63:1311-1317.
3. Darveau, R. P., and R. E. W. Hancock. 1983. Procedure for isolation of bacterial lipopolysaccharides from both smooth and rough Pseudomonas aeruginosa and Salmonella typhimurium strains. J. Bacteriol. 155:831-838.
4. Delude, R. L., R. Savedra Jr., H. Zhao, R. Thieringer, S. Yamamoto, M. J. Fenton, and D. T. Golenbock. 1995. CD14 enhances cellular responses to endotoxin without imparting ligand-specific recognition. Proc. Natl. Acad. Sci. USA 92:9288-9292.
5. Ferrero, E., C.-L. Hsieh, U. Francke, and W. S. M. Goyert. 1990. CD14 is a member of the family of leucine-rich proteins and is encoded by a gene syntenic with multiple receptor genes. J. Immunol. 145:331-336.
6. Frey, E. A., D. S. Miller, T. G. Jahr, A. Sundan, V. Bazil, T. Espevik, B. B. Fiulay, and S. D. Wright. 1992. Soluble CD14 participates in the response of cells to lipopolysaccharide. J. Exp. Med. 176:1665-1671.
7. Gegner, J. A., R. J. Ulevitch, and P. S. Tobias. 1995. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J. Biol. Chem. 270:5320-5325.
8. Genta, R. M., G. M. Lew, and D. Y. Graham. 1993. Changes in the gastric mucosa following eradication of Helicobacter pylori. Mod. Pathol. 6:281-289.
9. Hailman, E., H. S. Lichenstein, M. M. Wurfel, D. S. Miller, D. A. Johnson, M. Kelley, L. A. Busse, M. M. Znkowski, and S. D. Wright. 1994. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14. J. Exp. Med. 179:269-277.
10. Han, J., J. C. Mathison, R. J. Ulevitch, and P. S. Tobias. 1994. Lipopoly-saccharide (LPS) binding protein, truncated at Ile-197, binds LPS but does not transfer LPS to CD14. J. Biol. Chem. 269:8172-8175.
11. Haziot, A., G.-W. Rong, J. Silver, and S. M. Goyert. 1993. Rccombinant soluble CD 14 mediates the activation of endothelial cells by lipopolysaccharide. J. Immunol. 151:1500-1507.
12. Henderson, P. J. F. 1993. Statistical analysis of enzyme kinetic data, p. 277-291. In R. Eisenthal and M. J. Danson (ed.), Enzyme assays, a practical approach. IRL Press, New York.
13. Hollenbaugh, D., and A. Aruffo. 1994. Construction of immunoglobulin fusion proteins, p. 10.19.1-10.19.11. In J. E. Coligan, A. M. Kruisbeek, D. H. Marqulies, E. M. Shevach, and W. Strober (ed.), Current protocols in immunology. John Wiley & Sons, Inc., Washington, D.C.
14. Hollenbaugh, D., J. Douthwright, V. McDonald, and A. Aruffo. 1995. Cleavable CD40Ig fusion proteins and the binding to sgp39. J. Immunol. Methods 188:1-7.
15. Hollenbaugh, D., L. S. Grosmaire, C. D. Kullas, N. J. Chalupny, S. Braesch-Andersen, R. J. Noelle, I. Stamenkovic, J. A. Ledbetter, and A. Aruffo. 1992. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J. 11:4313-4321.
16. Holt, S. C., J. Ebersole, J. Felton, M. Brunsvold, and K. S. Kornman. 1988. Implantation of Bacteroides gingivalis in nonhuman primates initiates progression of periodontitis. Science 239:55-57.
17. Juan, T. S.-C., M. J. Kelley, D. A. Johnson, L. A. Busse, E. Hailman, S. D. Wright, and H. S. Lichenstein. 1995. Soluble CD14 truncated at amino acid 152 binds lipopolysaccharide (LPS) and enables cellular response to LPS. J. Biol. Chem. 270:1382-1387.
18. Kirikae, F., T. Kirikae, N. Qureshi, K. Takayama, D. C. Morrison, and M. Nakano. 1995. CD14 is not involved in Rhodobacter sphaeroides diphosphoryl lipid A inhibition of tumor necrosis factor alpha and nitric oxide induction by taxol in murine macrophages. Infect. Immun. 63:486-497.
19. Kirkland, T. N., F. Finley, D. Leturcq, A. Moriarty, J.-D. Lee, R. J. Ulevitch, and P. S. Tobias. 1993. Analysis of lipopolysaccharide binding to CD14. J. Biol. Chem. 268:24818-24823.
20. Kitchens, R. L., and R. S. Munford. 1995. Enzymatically deacylated lipo- polysaccharide (LPS) can antagonize LPS at multiple sites in the LPS recognition pathway. J. Biol. Chem. 270:9904-9910.
21. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256:495-497.
22. Lagrost, L., L. Persegol, C. Lallemant, and P. Gambert. 1994. Influence of apolipoprotein composition of high density lipoprotein particles on cholesteryl ester transfer protein activity. J. Biol. Chem. 269:3189-3197.
23. Loppnow, H., F. Steller, U. Schonbeck, C. Schluler, M. Ernst, C. Schutt, and H.-D. Had. 1995. Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14. Infect. Immun. 63:1020-1026.
24. Lynn, W. A., Y. Liu, and D. T. Golenbock. 1993. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide. Infect. Immun. 61:4452-4461.
25. Mai, U. E. H., G. I. Perez-Perez, L. M. Wahl, S. M. Wahl, M. J. Blaser, and P. D. Smith. 1991. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J. Clin. Invest. 87:894-900.
26. Mc-Ginley, M. D., L. O. Narhi, M. J. Kelley, E. Davy, J. Robinson, M. F. Rohde, S. D. Wright, and H. S. Lichenstein. 1995. CD14: physical properties and identification of an exposed site that is protected by lipopolysaccharide. J. Biol. Chem. 270:5213-5218.
27. Moran, A. P., I. M. Helander, and T. U. Kosunen. 1992. Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J. Bacteriol. 174:1370-1377.
28. Muotiala, A., I. M. Helander, L. Pyhala, T. U. Kosunen, and A. P. Moran. 1992. Low biological activity of Helicobacter pylori lipopolysaccharide. Infect. Immun. 60:1714-1716.
29. Ogawa, T. 1993. Chemical structure of lipid A from Porphyromonas (Bacteroides) gingivalis lipopolysaccharide. FEBS Lett. 332:197-201.
30. Ogawa, T., H. Uchida, and K. Amino. 1994. Immunobiological activities of chemically defined lipid A from lipopolysaccharides of Porphyromonas gingivalis. Microbiology 140:1209-1216.
31. Page, R. C. 1991. The role of inflammatory mediators in the pathogenesis of periodontal disease. J. Periodont. Res. 26:230-242.
32. Perez-Perez, G. I., V. L. Shepherd, J. D. Morrow, and M. J. Blaser. 1995. Activation of human THP-1 cells and rat bone marrow-derived macrophages by Helicobacter pylori lipopolysaccharide. Infect. Immun. 63:1183-1187.
33. Pugin, J., D. Heumann, A. Tomasz, V. V. Kravchenko, Y. Akamatsu, M. Nishijima, M. P. Glauser, P. S. Tobias, and R. J. Ulevitch. 1994. CD14 is a pattern recognition receptor. Immunity 1:509-516.
34. Pugin, J., C.-C. Schurer-Maly, D. Leturcq, A. Moriarty, R. J. Ulevitch, and P. S. Tobias. 1993. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. Proc. Natl. Acad. Sci. USA 90:2744-2748.
35. Rateliffe, K. 1996. Unpublished data.
36. Schumann, R. R., S. R. Leong, G. W. Flagg, P. W. Gray, S. D. Wright, J. C. Mathison, P. S. Tobias, and R. J. Ulevitch. 1990. Structure and function of lipopolysaccharide binding protein. Science 249:1429-1431.
37. Shahamat, M., U. E. H. Mai, C. Paszko-Kolva, H. Yamamoto, and R. R. Colwell. 1991. Evaluation of liquid media for growth of Helicobacter pylori. J. Clin. Microbiol. 29:2835-2837.
38. Shapira, L., S. Takashiba, S. Amar, and T. E. Van Dyke. 1994. Porphyromo- nan gingivalis lipopolysaccharide stimulation of human monocytes: dependence on serum and CD14 receptor. Oral Microbiol. Immunol. 9:112-117.
39. Simmons, D. L., S. Tan, D. G. Tenen, A. Nicholson-Weller, and B. Seed. 1989. Monocyte antigen CD14 is a phospholipid anchored membrane protein. Blood 73:284-289.
40. Takada, H., and S. Kotani. 1992. Structure-function relationships of lipid A. p. 107-130. In D. C. Morrison and J. L. Ryan (ed.). Bacterial endotoxic lipopolysaccharides, vol. 1. Molecular biochemistry and cellular biology. CRC Press, Boca Raton, Fla.
41. Tam, M. R., T. M. Buchanan, E. G. Sandstrom, K. K. Holmes, J. S. Knapp, A. W. Siadak, and R. C. Nowinski. 1982. Serological classification of Neisseria ganorrhoeae with monoclonal antibodies. Infect. Immun. 36:1042-1053.
42. Theofan, G., A. H. Horwitz, R. E. Williams, P.-S. Liu, I. Chan, C. Birr, S. F. Carroll, K. Meszaros, J. B. Parent, H. Kasler, S. Aberle, P. W. Trown, and H. Gazzano-Santoro. 1994. An amino-terminal fragment of human lipopolysaccharide-binding protein retains lipid A binding but not CD14-stimulatory activity. J. Immunol. 152:3623-3629.
43. Tobias, P. S., J. Mathison, D. Mintz, J. D. Lee, V. Kravchenko, K. Kato, J. Pugin, and R. J. Ulevitch. 1992. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation. Am. J. Respir. Cell. Mol. Biol. 7:239-245.
44. Tobias, P. S., J. C. Mathison, and R. J. Ulevitch. 1988. A family of lipopolysaccharide binding proteins involved in responses to gram-negative sepsis. J. Biol. Chem. 263:13479-13481.
45. Tobias, P. S., K. Soldau, J. A. Gegner, D. Mintz, and R. J. Ulevitch. 1995. Lipopolysaccharide binding protein-mediated complexation of lipopolysaccharide with soluble CD14. J. Biol. Chem. 270:10482-10488.
46. Ulevitch, R. J., and P. S. Tobias. 1994. Recognition of endotoxin by cells leading to transmembrane signaling. Curr. Opin. Immunol. 6:125-130.
47. Viriyakosol, S., and T. N. Kirkland. 1995. A region of human CD14 required for lipopolysaccharide binding. J. Biol. Chem. 270:361-368.
48. Westphal, O., and K. Jann. 1965. Bacterial lipopolysaccharides: extraction with phenol-water and further applications of the procedure, p. 83-91. In R. L. Whistler (ed.), Methods in carbohydrate chemistry. Academic Press. Inc., New York.
49. Wood, W. B., J. H. Wilson, R. M. Benbow, and L. E. Hood. 1995. Enzyme kinetics, p. 144-151. In Biochemistry: a problems approach. The Benjamin/ Cummings Publishing Company, Menlo Park, Calif.
50. Wright, S. D. 1995. CD14 and innate recognition of bacteria. J. Immunol. 155:6-8.
51. Wright, S. D., R. A. Ramos, P. S. Tobias, R. J. Ulevitch, and J. C. Mathison. 1990. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
52. Yoshida, N., D. N. Granger, D. J. Evans Jr., D. G. Evans, D. Y. Graham, D. C. Anderson, R. E. Wolf, and P. R. Kvietys. 1993. Mechanisms involved in Helicobacter prlori-induced inflammation. Gastroenterology 105:1431-1440.
53. Zambon, J. J. 1990. Microbiology of periodontal disease, p. 147-160. In R. J. Genco, H. M. Goldman, and D. W. Cohen (ed.). Contemporary periodontics. The C. V. Mosby Co., St. Louis.
54. Zhang, X.-M., I. Weber, and M. Chen. 1992. Site-directed mutational analysis of human tumor necrosis factor-a receptor binding site and structure-functional relationship. J. Biol. Chem. 267:24069-24075.